These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3296209)

  • 41. Lymphoblastic lymphoma in adults.
    Slater DE; Mertelsmann R; Koziner B; Higgins C; McKenzie S; Schauer P; Gee T; Straus D; Kempin S; Arlin Z
    J Clin Oncol; 1986 Jan; 4(1):57-67. PubMed ID: 3510283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of adult acute lymphoblastic leukemia. Preliminary results of a trial from the French Group.
    Fière D; Archimbaud E; Extra JM; Marty M; David B; Witz F; Sotto JJ; Rochant H; Gastaut JA; Le Prise PY
    Haematol Blood Transfus; 1987; 30():125-9. PubMed ID: 3305189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission.
    Stein AS; O'Donnell MR; Chai A; Schmidt GM; Nademanee A; Parker PM; Smith EP; Snyder DS; Molina A; Stepan DE; Spielberger R; Somlo G; Margolin KA; Vora N; Lipsett J; Lee J; Niland J; Forman SJ
    J Clin Oncol; 1996 Aug; 14(8):2206-16. PubMed ID: 8708709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modified chemotherapy with carmustine, cytarabine, cyclophosphamide, and 6-thioguanine (BACT) and autologous bone marrow transplantation in 24 poor-risk patients with acute lymphoblastic leukemia.
    Pico JL; Hartmann O; Maraninchi D; Beaujean F; Benhamou E; Mascret B; Novakovitch G; Ghalie R; Kalifa C; Hayat M
    J Natl Cancer Inst; 1986 Jun; 76(6):1289-93. PubMed ID: 3520070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience.
    Cassileth PA; Andersen JW; Bennett JM; Hoagland HC; Mazza JJ; O'Connell MC; Paietta E; Wiernik P
    Leukemia; 1992; 6 Suppl 2():178-81. PubMed ID: 1578927
    [No Abstract]   [Full Text] [Related]  

  • 46. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapy for adolescent and adult acute lymphoblastic leukemia: randomization of induction and consolidation therapies (preliminary results of EORTC Study 58791).
    Stryckmans P; Marie JP; Suciu S; Solbu G; Debusscher L; Bury J; Peetermans M; Andrien JM; Fière D; Cauchie C
    Haematol Blood Transfus; 1987; 30():130-6. PubMed ID: 3305190
    [No Abstract]   [Full Text] [Related]  

  • 48. Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
    Morra E; Lazzarino M; Inverardi D; Brusamolino E; Orlandi E; Canevari A; Pagnucco G; Bernasconi C
    J Clin Oncol; 1986 Aug; 4(8):1207-11. PubMed ID: 3461134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Advances in the treatment of acute myeloid leukemia in children. Experience of the Argentinian Group of Acute Leukemia Treatment and the Latin American Group of Malignant Hemopathies Treatment 1967-1987].
    Freigeiro D; Scaglione C; Santarelli MT; Sackmann Muriel F; Jiménez E; Pavlovsky S; Bustelo P; Richard L; Kohan R; Kvicala R
    Sangre (Barc); 1989 Jun; 34(3):221-8. PubMed ID: 2669186
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
    Tallman MS; Appelbaum FR; Amos D; Goldberg RS; Livingston RB; Mortimer J; Weiden PL; Thomas ED
    J Clin Oncol; 1987 Jun; 5(6):918-26. PubMed ID: 3585446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A single high dose of idarubicin combined with high-dose ARA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University "La Sapienza" of Rome.
    Testi AM; Moleti ML; Giona F; Annino L; Chiaretti S; Del Giudice I; Todisco E; D'Elia G; Ferrari A; Arcese W; Mandelli F
    Haematologica; 1997; 82(6):664-7. PubMed ID: 9499665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
    Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study].
    Stahnke K; Ritter J; Schellong G; Beck JD; Kabisch H; Lampert F; Creutzig U
    Klin Padiatr; 1992; 204(4):253-7. PubMed ID: 1518261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
    Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L.
    Dahl GV; Rivera GK; Look AT; Hustu HO; Kalwinsky DK; Abromowitch M; Mirro J; Ochs J; Murphy SB; Dodge RK
    J Clin Oncol; 1987 Jul; 5(7):1015-21. PubMed ID: 3474355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination chemotherapy for acute lymphocytic leukaemia in 25 adults.
    de Vries EG; Mulder NH; Houwen B; Haaxma-Reiche H
    Blut; 1982 Mar; 44(3):151-8. PubMed ID: 6952951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DNA as a carrier for anthracyclines in the treatment of acute myelocytic leukemia (AML).
    Gahrton G; Tidefelt U; Paul C; Björkholm M; Grimfors G; Hast R; Juliusson G; Järnmark M; Killander A; Kimby E
    Leukemia; 1992; 6 Suppl 2():89-91. PubMed ID: 1578953
    [No Abstract]   [Full Text] [Related]  

  • 58. Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.
    Zittoun R; Marie JP; Zittoun J; Marquet J; Haanen C
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):139-43. PubMed ID: 3859928
    [No Abstract]   [Full Text] [Related]  

  • 59. Drugs five years later: cytarabine.
    Kremer WB
    Ann Intern Med; 1975 May; 82(5):684-8. PubMed ID: 1056159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Usefulness of cytosine arabinoside (NSC-63878) and prednisone (NSC-10023) in refractory childhood lymphoblastic leukemia.
    Nesbit ME; Sonley M; Hammond D
    Med Pediatr Oncol; 1976; 2(1):61-8. PubMed ID: 1064743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.